Based on the correlation of transitional CXCL14+ myCAFs with tumour staging, we prospectively collected plasma samples from stage I (n = 12), stage II and III (n = 13) and stage IV (n = 14) LUAD patients (patients information shown in Table S5) to measure the cytokine CXCL14. Here, CXCL14 is linked to neoplasm.